An Ankyrin-like Protein with Transmembrane Domains Is Specifically Lost after Oncogenic Transformation of Human Fibroblasts

Daniel Jaquemar, T. Schenker, Beat Trüeb

Journal of Biological Chemistry · 1999 · 325 citations · 27 references

DOIFull text

Open access

Concepts

Abstract

We have identified a novel transformation-sensitive mRNA, which is present in cultured fibroblasts but is lacking in SV40 transformed cells as well as in many mesenchymal tumor cell lines. The corresponding gene is located on human chromosome 8 in band 8q13. The open reading frame of the mRNA encodes a protein of 1119 amino acids forming two distinct domains. The N-terminal domain consists of 18 repeats that are related to the cytoskeletal protein ankyrin. The C-terminal domain contains six putative transmembrane segments that resemble many ion channels. This overall structure is reminiscent of TRP-like proteins that function as store-operated calcium channels. The novel protein with anMr of 130 kDa is expressed at a very low level in human fibroblasts and at a moderate level in liposarcoma cells. Overexpression in eukaryotic cells appears to interfere with normal growth, suggesting that it might play a direct or indirect role in signal transduction and growth control. We have identified a novel transformation-sensitive mRNA, which is present in cultured fibroblasts but is lacking in SV40 transformed cells as well as in many mesenchymal tumor cell lines. The corresponding gene is located on human chromosome 8 in band 8q13. The open reading frame of the mRNA encodes a protein of 1119 amino acids forming two distinct domains. The N-terminal domain consists of 18 repeats that are related to the cytoskeletal protein ankyrin. The C-terminal domain contains six putative transmembrane segments that resemble many ion channels. This overall structure is reminiscent of TRP-like proteins that function as store-operated calcium channels. The novel protein with anMr of 130 kDa is expressed at a very low level in human fibroblasts and at a moderate level in liposarcoma cells. Overexpression in eukaryotic cells appears to interfere with normal growth, suggesting that it might play a direct or indirect role in signal transduction and growth control. Fibroblasts transformed by tumor viruses are often used in the laboratory as a model system to investigate transformation-associated changes in the phenotype and in the adhesive properties of the cells (1Pastan I. Willingham M. Nature. 1978; 274: 645-650Crossref PubMed Scopus (105) Google Scholar, 2Dubbelman T.M.A.R. Yamada K.M. Biochim. Biophys. Acta. 1982; 693: 177-187Crossref PubMed Scopus (4) Google Scholar). Usually these fibroblasts exhibit a roundish shape and show reduced adhesion to their substratum similar to authentic tumor cells. In contrast to spontaneous cancer cells, virally transformed fibroblasts have the advantage that the normal counterpart, the original cell, is available for comparative studies. A set of transformation-sensitive proteins that are expressed by normal fibroblasts but specifically repressed after oncogenic transformation has emerged from these studies. The best known example is fibronectin, an important adhesion protein of the extracellular matrix (3Hynes R.O. Fibronectins. Springer-Verlag, New York1990Crossref Google Scholar). It is likely that the down-regulation of fibronectin and the other transformation-sensitive proteins contributes to the establishment of the transformed phenotype and to the unrestricted growth of tumor cells. We have recently used this model system in combination with a subtractive cDNA cloning approach to identify novel transformation-sensitive proteins (4Schenker T. Lach C. Kessler B. Calderara S. Trueb B. J. Biol. Chem. 1994; 269: 25447-25453Abstract Full Text PDF PubMed Google Scholar, 5Schenker T. Trueb B. Exp. Cell. Res. 1998; 239: 161-168Crossref PubMed Scopus (43) Google Scholar). Our efforts led to the isolation of more than 40 cDNA clones that showed a dramatic reduction in their relative synthesis after oncogenic transformation. The proteins encoded by these clones could be grouped into four distinct classes (5Schenker T. Trueb B. Exp. Cell. Res. 1998; 239: 161-168Crossref PubMed Scopus (43) Google Scholar): cytoskeletal proteins (e.g. vinculin, SM22), extracellular matrix proteins (e.g. fibronectin, collagen VI), proteolytic enzymes (e.g. collagenase, urokinase), and regulatory proteins (e.g. IGFBP-5, myosin kinase). Six novel gene products were discovered during our study, including a GTP-binding protein (4Schenker T. Lach C. Kessler B. Calderara S. Trueb B. J. Biol. Chem. 1994; 269: 25447-25453Abstract Full Text PDF PubMed Google Scholar), a zyxin-like protein (6Zumbrunn J. Trueb B. Eur. J. Biochem. 1996; 241: 657-663Crossref PubMed Scopus (24) Google Scholar), and a novel serine protease (7Zumbrunn J. Trueb B. FEBS Lett. 1996; 398: 187-192Crossref PubMed Scopus (188) Google Scholar). Here we set out to characterize one of the new cDNA clones. This clone codes for an integral membrane protein with 18 ANK repeats. The polypeptide appears to combine the features of the cytoskeletal protein ankyrin with those of an ion channel. The function of the novel protein remains obscure, although there is circumstantial evidence that it might be involved in a growth regulatory pathway. A cDNA clone of 207 bp 1The abbreviations used are: bp, base pair(s); APH, aminoglycoside phosphotransferase; DAPI, 4,6-diamino-2-phenylindole; DMEM, Dulbecco's modified Eagle's medium; FISH, fluorescence in situ hybridization; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; TRP, transient receptor potential protein; TRPL, TRP-like protein; MOPS, 3-(N-morpholino)propanesulfonic acid that originated from a subtracted cDNA library (4Schenker T. Lach C. Kessler B. Calderara S. Trueb B. J. Biol. Chem. 1994; 269: 25447-25453Abstract Full Text PDF PubMed Google Scholar, 5Schenker T. Trueb B. Exp. Cell. Res. 1998; 239: 161-168Crossref PubMed Scopus (43) Google Scholar) was labeled with [α-32P]dCTP by the random primed oligo-labeling method (8Feinberg A. Vogelstein B. Anal. Biochem. 1983; 132: 6-13Crossref PubMed Scopus (16651) Google Scholar). This probe was used to screen approximately 0.5 × 106 recombinant phages of a commercial cDNA library, which had been prepared from human lung fibroblasts (HL1011,CLONTECH Laboratories) by the plaques hybridization technique (9Benton W.D. Davis R.W. Science. 1977; 196: 180-182Crossref PubMed Scopus (2924) Google Scholar). Positive colonies were picked, amplified, and subcloned into the plasmid pUC19 following standard procedures (10Ausubel F.M. Brent R. Kingston R.E. Moore D.D. Seidman J.G. Smith J.A. Struhl K. Current Protocols in Molecular Biology. Greene Publishing Associates, New York1987Google Scholar). To obtain the 5′ end of the cDNA, the RACE technique was applied using methyl mercuric hydroxide-denatured mRNA from human fibroblasts (IMR90) and the AmpliFINDER RACE kit (CLONTECH). Two synthetic oligonucleotide primers were prepared for this purpose corresponding to the cDNA sequence (reverse primer nucleotides 523–547, nested primer nucleotides 439–466). The sequences of the isolated cDNA clones were determined on both strands by the dideoxy chain termination technique (11Sanger F. Nicklen S. Coulson A.R. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 5463-5467Crossref PubMed Scopus (52771) Google Scholar) using Sequenase 2.0 (U. S. Biochemical Corp.). To resolve ambiguities observed in the 5′ region, suitable restriction fragments were subcloned into the sequencing vectors M13mp18 and M13mp19 and subsequently sequenced in the presence of dITP instead of dGTP. All sequences were analyzed with the software computer package of the Genetics Computer Group (University of Wisconsin, WI) using default settings unless otherwise stated. The sequences were compared with all entries of the EBI data bank (release 55.0) and the Swissprot data bank (release 36.0). Total RNA was extracted from confluent cell layers by the SDS/proteinase K method (12Rowe D.W. Moen R.C. Davidson J.M. Byers P.H. Bornstein P. Palmiter R.D. Biochemistry. 1978; 17: 1581-1590Crossref PubMed Scopus (170) Google Scholar). For some experiments this RNA was further purified by chromatography on oligo(dT)-cellulose utilizing an mRNA isolation kit (Amersham Pharmacia Biotech). The RNA (15 μg total RNA or 2 μg of poly(A+) RNA/lane) was resolved on 1% agarose gels in the presence of 1 mformaldehyde and transferred to nylon membranes by vacuum blotting (10Ausubel F.M. Brent R. Kingston R.E. Moore D.D. Seidman J.G. Smith J.A. Struhl K. Current Protocols in Molecular Biology. Greene Publishing Associates, New York1987Google Scholar). The membranes were hybridized with radiolabeled cDNA probes at 42 °C in a buffer containing 50% formamide. After being washed at regular stringency (10Ausubel F.M. Brent R. Kingston R.E. Moore D.D. Seidman J.G. Smith J.A. Struhl K. Current Protocols in Molecular Biology. Greene Publishing Associates, New York1987Google Scholar), the membranes were exposed to BioMax MS film (Kodak, Rochester, NY) or analyzed with a phosphorimager (Storm 840, Molecular Dynamics, Sunnyvale, CA). The multiple tissue Northern blots used in this study contained poly(A+) RNA from 16 adult human tissues (MTN I, MTN II,CLONTECH) and total RNA from 4 fetal human tissues (Northern Territory Human Fetal Tissue, Invitrogen, San Diego, CA). All these blots were processed as described above. Competitive PCR was as described by S. K. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). was into cDNA with of using a cDNA synthesis kit The was primed with an oligonucleotide corresponding to of the cDNA of the cDNA were with polymerase in the presence of of at at and at The primer for this PCR to of the cDNA, the primer was compared with the one used for For the PCR was with of a This of the restriction from the cDNA which in nucleotides from of this a amplification of the authentic cDNA a The PCR products were resolved on a and with The of cDNA was by the of that had to be to the PCR in to obtain of the and human fibroblasts as well as transformed cell were from the and All cells were at °C an of in with fetal and For the cells were with a into an buffer containing protease and by and proteins were further into membrane and proteins as described K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The of the gene was determined by as described J. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, J. Trueb B. PubMed Scopus Google Scholar). of human were prepared from and on of the cDNA clones was labeled with and hybridized at °C to the in a buffer containing 50% formamide. After being the were with and with The signal and the were J. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, J. Trueb B. PubMed Scopus Google Scholar). were a synthetic corresponding to amino acids of A was at the of the to to the protein The was into two at B. J. PubMed Scopus Google Scholar, a Scholar). After the was and the were purified from the by chromatography following standard procedures a Scholar). For this purpose an was prepared that the of expressed as a restriction corresponding to amino acids was into the (Amersham Pharmacia in the reading This was into and expressed after with The were by and by in MOPS, After of the cell with the the protein was extracted with MOPS, This was to to the of the The purified were in an as described B. J. PubMed Scopus Google Scholar, a Scholar). For cell proteins were on gels Nature. PubMed Scopus Google Scholar) and transferred to B. J. PubMed Scopus Google Scholar, T. J. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). After had been with the was with at a of to were with a by with A was by of restriction fragments from our cDNA clones into the The contained nucleotides into the of the and reading frame were by The was into cells for transient or into human cells and for To this the cells were in with to 50% and the plasmid was with 8 of in a total of 2 of from After an of the was with with and the cells were to for colonies were in the presence of a of (10Ausubel F.M. Brent R. Kingston R.E. Moore D.D. Seidman J.G. Smith J.A. Struhl K. Current Protocols in Molecular Biology. Greene Publishing Associates, New York1987Google Scholar). Total RNA was extracted from colonies with the kit from of the gene was analyzed by Northern blotting using the cDNA for as a of the gene was with a radiolabeled restriction from We have on the of a subtracted cDNA library for clones that are expressed by normal but by SV40 transformed human fibroblasts (4Schenker T. Lach C. Kessler B. Calderara S. Trueb B. J. Biol. Chem. 1994; 269: 25447-25453Abstract Full Text PDF PubMed Google Scholar, 5Schenker T. Trueb B. Exp. Cell. Res. 1998; 239: 161-168Crossref PubMed Scopus (43) Google Scholar). of the clones from this library our was oncogenic transformation. This clone was and to for a novel The clone was used as a probe to screen a commercial cDNA library prepared from human fibroblasts with the to the for the novel After four of we but of all the to the 5′ end of the corresponding The RACE technique was to the 5′ which in the isolation of clones. the cDNA clones a sequence of bp This sequence with a 5′ of bp that was in the nucleotides and C. The at was by two in frame This putative was by an open reading frame of nucleotides that in the After the there was a sequence of nucleotides which two at and The sequence of the probe used for was at The open reading frame a protein of 1119 amino acids with a of kDa and an of In the this polypeptide be It contains potential of the but two are likely to be used for and these are in the of the novel protein computer that the novel polypeptide be into two an N-terminal that is related to the cytoskeletal protein ankyrin and a C-terminal that is related to transmembrane The N-terminal 18 repeats of amino acids of these repeats amino acid are with the from proteins J. Biol. Chem. Full Text PDF PubMed Google Scholar, P. Biol. Full Text PDF PubMed Scopus Google Scholar, Google Scholar). repeats of the ANK the but are otherwise related to the ANK this it likely that the N-terminal of the novel protein from an ANK that was during ANK in a of proteins with J. Biol. Chem. Full Text PDF PubMed Google Scholar, P. Biol. Full Text PDF PubMed Scopus Google Scholar, Google Scholar), including cytoskeletal proteins and The C-terminal of the novel polypeptide segments of amino acids which as transmembrane domains. A to and J. J. Biol. 1982; PubMed Scopus Google Scholar) these segments at and on the of A. Biophys. Chem. PubMed Scopus Google Scholar) but this one of at instead of It is that six of the segments function as transmembrane one of the at which contains the membrane but the This structure is reminiscent of some ion which six transmembrane and a the R. Full Text PDF PubMed Scopus Google Scholar, Cell. Full Text PDF PubMed Scopus Google Scholar). the polypeptide a signal at an as signal as for example with the of the cell membrane Google Scholar, J. Biol. Chem. 1994; 269: Full Text PDF PubMed Google Scholar). The of membrane proteins be by of to the transmembrane domain Eur. J. Biochem. PubMed Scopus Google Scholar). that the novel protein a in which the N-terminal domain with all the ANK repeats at the of the cell membrane as in In this the two at and in the extracellular and be for by It is that this structure by In to the ANK repeats and to the transmembrane the protein contains an N-terminal of and a C-terminal of of these segments to known protein The amino acid sequence of the novel protein was compared with all entries of the Swissprot data were that to the cytoskeletal protein ankyrin and to other proteins containing ANK repeats. In to these we one protein that had emerged from the of the a of and an of an with or and the of the two including the ANK repeats and the transmembrane is known the function of the C. protein as it was by computer of the the of the structure two related a function of the new The cDNA sequence of was compared with all expressed sequence in the data cDNA clones were that our cDNA sequence and all these clones were from human tumor and which were analyzed in the of the The of this is The of the novel gene was analyzed by Northern blotting a containing RNA from of human fibroblasts our cDNA clones hybridized to a band of This is in with the of our cDNA sequence a of RNA from SV40 transformed fibroblasts signal was that of the corresponding gene was after oncogenic transformation. To of the gene was repressed in virally transformed fibroblasts or this down-regulation was a of transformed cells, we analyzed cell from spontaneous mesenchymal from four two an and a of the two cell were the mRNA was at a low level in but in the cells from a liposarcoma contained of the of the Northern with a probe for that all contained similar of the of the mRNA is a of but mesenchymal tumor cells. We the tissues might the novel To this end our probes were hybridized to commercial Northern blots containing mRNA from adult human including and To our we were to signal that was than a Northern containing RNA from four fetal human tissues and distinct of the blots with probes for or that all the blots contained normal of It appears that all the human tissues low of the mRNA, which be by Northern We used a very PCR approach to of the gene in normal human tissues The mRNA was into cDNA and used as for A of primers was which amplification of a corresponding to the and putative transmembrane were we have evidence that are encoded by two and B. For a was used as an This of the sequence but an sequence of bp in to and the cDNA on a The was to the at a cDNA to amplification of the was at a low amplification of the The of cDNA in the could be from the and cDNA were in this technique to mRNA from the band of bp was of the and the were × 106 of the were to the This to approximately of mRNA RNA from a human was analyzed in a similar the band of bp was that the gene was in expressed in human experiments that these tissues contained at a level of mRNA than RNA from an which was by this method The were set of PCR primers was the gene is in human tissues but at an low To further characterize the we set out to in the human by the a probe prepared from our cDNA clones was hybridized to of human a signal was observed on the of chromosome 8 showed on at one of The as determined by the signal with the was to be band 8q13. was The gene for the novel protein is at a on human chromosome It might be of to that the gene for ankyrin 1 is located on this in Google Scholar). In an to characterize the protein encoded by the were a synthetic amino acids from the of the polypeptide In the their at the other for or indirect were a which be in the on the with a expressed protein the C-terminal domain of We used blotting to protein from liposarcoma cells, which a level of the mRNA as above. A total cell but an for membrane proteins showed a band with an of 130 kDa and with than kDa It is likely that the band to the of the mRNA, the proteins with our as were with all other a membrane from fibroblasts was analyzed in a similar a very band of 130 kDa was In in the were observed with membrane from SV40 transformed fibroblasts or cells. liposarcoma cells and fibroblasts at a low but For a of the novel we to of in human cells. To this a cDNA was into and cells. Positive were by their to the and colonies were on Northern blots for their of the mRNA a very colonies were and more one of was to a mRNA related to a that this the mRNA, but a of than nucleotides that a protein of the Northern with a cDNA probe for the gene that all cells in the a of cells was to a signal corresponding to the mRNA was this signal after the signal were transient were with cells. We that of the mRNA is in cells, by of the cDNA or by of the to these is that the of is with the normal growth of human cells. subtractive cDNA we have identified a novel gene on human chromosome 8 that codes for a transformation-sensitive protein we have of the and we have been to the function of this The was by the of the novel gene as The mRNA for was expressed by cultured but it was specifically repressed after oncogenic transformation. on a PCR we that a contains of the mRNA, which to a gene that is expressed at moderate In contrast a of mesenchymal tumor cell at with the of liposarcoma cells that contained a level of the The protein encoded by the mRNA could be in but it was at a moderate level in liposarcoma cells. these cells a level of the mRNA, the protein very or it is with very is evidence in of the of the mRNA an of amino acid the In contrast to was expressed at a very low level in human could be by Northern but a very PCR approach for on a PCR we that the tissues of a human a level of the mRNA than It is that the gene is at a very by cells. our Northern blotting experiments with adult and tissues and our with in this It more likely that cells the gene at a very low level for a very during their The low of is by the that the data bank of expressed sequence contains clones that with our All these clones are from human tumor Overexpression of the cDNA in normal and transformed cells has been of an the A of our experiments that the of the novel protein might be to the cells. The low of in human tissues might a function of the novel protein in an as regulatory pathway. This is by the of the protein sequence related as and the mRNA is at a moderate level in cultured but at very low level in human is to fetal the tissue from which the fibroblasts had been a very low level of the mRNA that was by Northern blotting It appears that of the cells from their and in to the of the mRNA, which is into This to be by oncogenic as SV40 transformed fibroblasts as well as mesenchymal tumor cells the The normal and transformed cells as well as fibroblasts in tissues and fibroblasts in are related to the and adhesive properties of the cells (1Pastan I. Willingham M. Nature. 1978; 274: 645-650Crossref PubMed Scopus (105) Google Scholar, 2Dubbelman T.M.A.R. Yamada K.M. Biochim. Biophys. Acta. 1982; 693: 177-187Crossref PubMed Scopus (4) Google Scholar). In a study we have analyzed the of we could changes in the mRNA level fibroblasts on fibroblasts on and fibroblasts a collagen The of the gene is by the shape or the of the cells. A to the function of might be from a of The N-terminal of the protein contains ANK a that is in some cytoskeletal some and some membrane J. Biol. Chem. Full Text PDF PubMed Google Scholar, P. Biol. Full Text PDF PubMed Scopus Google Scholar, Google Scholar). A of ANK in the cytoskeletal protein which contains and in an and membrane ANK repeats. It is that the ANK an important role in 1 from has been in It has been to with a of other including and integral membrane A example of the is the of the membrane which is ankyrin to the Google Scholar). The C-terminal of contains six putative transmembrane and a features that are reminiscent of many ion R. Full Text PDF PubMed Scopus Google Scholar, Cell. Full Text PDF PubMed Scopus Google Scholar). It is that as an ion that is to a cytoskeletal similar to the Google Scholar). be in that it the of a and that of a cytoskeletal a polypeptide the gene is expressed at an low level it might play a regulatory are with the that it as an ion involved in signal All the features of are by of a of the TRP-like Biochem. J. PubMed Scopus Google and C. PubMed Scopus Google Scholar). and related protein were discovered in the as that the in the is of amino it an N-terminal signal but contains six and a and it four ANK repeats in N-terminal evidence that and of a Biochem. J. PubMed Scopus Google Scholar, C. PubMed Scopus Google Scholar). are by of from are in and and to be located in the membrane of and cells. proteins have been identified in (e.g. and All these TRP-like have a similar to although show a low at the amino acid M. M. R. Cell. 1996; Full Text Full Text PDF PubMed Scopus Google Scholar) as example or with a of amino acids corresponding to of the ANK repeats and of the transmembrane domains. This that a novel in the of TRP-like To that is an ion it is to our novel protein in a eukaryotic all our efforts in this have been the of to be with normal growth of the cells. it is that a domain than the could be expressed in eukaryotic cells. experiments with suitable fragments from our cDNA clones might on the function and of this We K. for

References

27